NFA
RGNX icon

Nationwide Fund Advisors’s Regenxbio RGNX Stock Holding History

Nationwide Fund Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-52,725
Closed -$1.74M – 1644
2017
Q3 		$1.74M Buy
52,725
+3,651
+7% +$82.2K 0.01% 1506
2017
Q2 		$969K Buy
49,074
+3,119
+7% +$60.4K ﹤0.01% 1792
2017
Q1 		$887K Buy
45,955
+3,280
+8% +$63.3K ﹤0.01% 1833
2016
Q4 		$792K Buy
42,675
+29,860
+233% +$571K ﹤0.01% 1911
2016
Q3 		$180K Hold
12,815
– – ﹤0.01% 2675
2016
Q2 		$103K Buy
12,815
+8,487
+196% +$94.2K ﹤0.01% 2905
2016
Q1 		$47K Sell
4,328
-34
-0.8% -$435 ﹤0.01% 2993
2015
Q4 		$72K Buy
+4,362
New +$86.6K ﹤0.01% 2929

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Nationwide Fund Advisors's RGNX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Regenxbio (RGNX) in Q4 2017, closing a stake of 52,725 shares — an estimated $1.74M sold.

Nationwide Fund Advisors first reported a position in RGNX in Q4 2015 and held it in 8 quarters. The position peaked at $1.74M in Q3 2017. 108 funds tracked by Wall St. Rank hold RGNX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Regenxbio position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 52,725 Regenxbio shares in Q4 2017, an estimated $1.74M.
  • Nationwide Fund Advisors first reported a position in Regenxbio in Q4 2015 and held it in 8 quarters.
  • Nationwide Fund Advisors's Regenxbio position peaked at $1.74M in Q3 2017.
  • 108 funds tracked by Wall St. Rank held Regenxbio as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.